Omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have protective roles preventing atherosclerosis, stroke, obesity, type-2 diabetes and inflammation. V ertebrates can only biosynthesise small amounts of LC-PUFA, at rates insufficient to meet physiological requirements . Marine fish and seafood, which obtain preformed LC-PUFA through trophic transfer, constitute the primary sources of n-3 LC-PUFA in the human diet . L imited availability, fluctuating price and sustainability concerns related to fish oil production are prompting the aquaculture industry to replace fish oil with vegetable oils in aquafeeds. Since vegetable oils are devoid of significant amounts of n -3 LC-PUFA while often containing high levels of omega-6 (n-6) PUFA, the replacement of fish oil-based diets with aquafeeds containing vegetable oils markedly reduces n -3 LC-PUFA, particular ly EPA and DHA, in the fish flesh, while increasing the levels of proinflammatory n -6 PUFA . To address changes in the global pattern of gene expression triggered by stimulation of n-3 LC-PUFA biosynthesis in fish , herein gilthead seabream ( Sparus aurata) juveniles were intraperitoneally administered with up to 3 doses (spaced at 4-week intervals) of chitosan-tripolyphosphate nanoparticles complexed with a plasmid driving the expression of fish codon-optimised Caenorhabditis elegans fat-1 , a Δ15/n -3 fatty acid desaturase absent in vertebrates.
The expression of C. elegans fat-1 significantly increased EPA, DHA and the n-3/n -6 fatty acid ratio. Additionally, an RNA-seq assay revealed that key biological processes were affected in the liver of S. aurata, including lipid metabolic process, macromolecule metabolic process, regulation of cellular process, oxidation-reduction process, and transmembrane transporter activity (Figure 1).
This study was supported by grant PID2021-125642OB-I00 fund ed by MICIU/AEI /10.13039/501100011033 and by ERDF/EU.